|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 231/38 | |
| A61K 31/415 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| A61P 31/04 | |||
| A61P 9/00 | |||
| A61K 9/00 | |||
| A61K 9/28 | |||
| A61K 9/48 |
| (11) | Patento numeris | 3080089 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14869792.3 |
| Europos patento paraiškos padavimo data | 2014-12-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/069487 |
| Data | 2014-12-10 |
| (87) | Numeris | WO 2015/089149 |
| Data | 2015-06-18 |
| (30) | Numeris | Data | Šalis |
| 201361914085 P | 2013-12-10 | US | |
| 201461979619 P | 2014-04-15 | US |
| (72) |
HURD, Alexander R., US
TAYLOR, Clarke B., US
WANG, Jian, US
ZHOU, Peng, CN
|
| (73) |
Lycera Corporation,
2800 Plymouth Rd. NCRC Building 26, Ann Arbor, MI 48109,
US
|
| (54) | TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF |
| TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1FO-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF |